Dear Shareholders,
It is my privilege to address you and present the Annual Report of Family Care Hospitals Limited for the Financial Year 2025-26. This year has represented a critical period of structural transition, asset preservation, and strategic realignment for our organization as we navigate an interim operational cycle.
As detailed in our corporate disclosures, your company faced unexpected operational challenges that necessitated the suspension of physical multi-specialty clinical operations at our flagship hospital facility. While handling these physical site disruptions and the associated legal parameters, our primary focus has been to safeguard our core organizational infrastructure, preserve resource stability, and maintain our corporate footprint within the healthcare sector. Rather than remaining stagnant, we have utilized this transition period to actively pivot towards non-physical healthcare delivery models, leveraging our established professional doctor registry and expanding our digital footprint through our specialized mobile applications and online platforms.
Our financial baseline during this cycle directly reflects the impact of suspending physical hospital operations. For the financial year ended March 31, 2026, the company recorded a net loss after tax of Rs. 868.28 lakhs. While this deficit underscores the challenges of our current transition, it represents a substantial structural stabilization compared to the net loss of Rs. 4,414.53 lakhs recorded in the preceding financial year. To counter the compression of operating revenues, the management team successfully implemented strict cost-containment measures across all corporate levels, rationalizing variable administrative costs, optimizing facility upkeep outlays, and scaling down employee benefit expenses to Rs. 49.17 lakhs to ensure strict resource efficiency.
Looking ahead, the singular and absolute priority of the Board of Directors and the management team is the comprehensive revival of the overall situation. We are pursuing a clear, multi-track recovery strategy to rebuild organizational strength and restore stakeholder value. On the legal track, we are taking diligent, structured steps through higher judicial and statutory appeal channels to systematically resolve our ongoing property, lease, and regulatory compliance hurdles, including the execution orders stemming from the historical Mahim lease dispute. On the operational track, we are optimizing our technology products, expanding our application features, and focusing on scaling digital healthcare revenues to rebuild institutional strength and build up sustainable capital reserves.
I want to put on record our sincere appreciation for our streamlined team of employees, our medical professionals, and our business partners who have shown great dedication during this period. Most importantly, I extend our deepest gratitude to you, our valued shareholders, for your patient trust, support, and understanding as we navigate this period of restructuring towards a stable and revived future.
With warm regards,
Suchit Raghunath Modshing Chairman and Whole-Time Director Family Care Hospitals Limited
BOARDS REPORT
Dear Members,
The Board of Directors are pleased to present the 32nd Annual Report of the Company along with the Audited Financial Statements for the financial year ended March 31, 2026.
1. FINANCIAL RESULTS AND HIGHLIGHTS:
The Financial performance of the Company for the year ended March 31, 2026 is summarized below:
| Particulars | March 31, 2026 | March 31, 2025 |
| Revenue from Operations | 20.97 | 790.46 |
| Other Income | 24.04 | 315.22 |
| Total | 45.02 | 1105.68 |
| Expenditure | ||
| Purchase of stock in trade | 10.18 | 63.88 |
| Change in inventory | - | (3752.64) |
| Employee Benefit Expenses | 49.17 | 217.76 |
| Finance Costs | 37.32 | 28.54 |
| Depreciation | 88.19 | 112.64 |
| Other Expenses | 286.48 | 1420.15 |
| Prior Period Expensess | 441.95 | - |
| Total | 913.30 | (1909.66) |
| Profit / (Loss) before Exceptional and | (868.28) | 3015.34 |
| Extraordinary Items and Tax | ||
| Exceptional items | - | (7462.00) |
| Extraordinary items | - | - |
| Profit / (Loss) from ordinary activities before tax | (868.28) | (4446.66) |
| Tax Expense | ||
| 1. Current Y ear Tax | - | - |
| 2. Deferred Tax Credit/(Charge) | - | (32.13) |
| 3. Earlier Year | - | - |
| Profit/ (Loss) after Tax | (868.28) | (4414.53) |
| Total Other Comprehensive income for the year | 0.83 | 12.48 |
| Total Comprehensive income / (loss) for the year | (867.45 | (4402.05) |
| Basic EPS | (1.16) | (8.17) |
| Diluted EPS | (1.16) | (8.17) |
2. INDIAN ACCOUNTING STANDARD:
The Financial Statements for the financial year ended March 31, 2026, forming part of this Annual Report, have been prepared in accordance with Ind AS.
3. COMPANYS PERFORMANCE:
The Companys revenue from operations during the Financial Year 2025-26 was Rs. 20.97 lakhs as against Rs. 790.46 lakhs for the previous financial year.
The loss after tax for period under review stood at Rs. (868.28) lakhs as against loss of Rs. (4402.05) lakhs for the previous financial year. The loss was mainly due to the effect of closure of our hospital at Mira road.
There has been no change in the nature of business of the Company during the year under review. Performance of the Company has also been discussed in detail in the Management Discussion and Analysis Report forming part of this Annual Report.
4. DIVIDEND:
During the year Company has not announced any dividend.
5. TRANSFER TO RESERVES:
No amount is proposed to be transferred to the General Reserves of the Company out of the profits for the year.
6. SUBSIDIARY:
During the year under review the Company does not have any Subsidiary Company.
7. CHANGES IN SHARE CAPITAL, IF ANY:
A. Increase in the Authorized Share Capital
During the year under Review, the Authorized share Capital of the Company is Rs. 75,00,00,000 (Rupees Seventy-Five Crore Only) divided into 7,50,00,000 (Seven Crore Fifty lakhs) Equity Shares of Rs. 10/- each share Whereas the paid up share capital of company is Rs. 54,01,47,740 (Rupees Fifty-Four Crore One Lakhs Forty-Seven Thousand Seven Hundred Forty) divided into 5,40,14,774 (Five Crore Forty Lakhs Fourteen Thousand Seven Hundred Forty Seventy-Four) Equity shares of Rs. 10/- each share.
During the review, no any change is made during the financial year 2025-26.
B. Issue of Securities on Preferential Basis
The Board has approved in its Meeting dated July 12, 2024 issuance of upto 1,75,00,000 (One Crore Seventy-Five Lakhs) Warrants, each convertible into, or exchangeable for, 1 (one) fully paid-up equity share of the Company of face value of INR 10/- each (Rupees Ten only) ("Warrants") at a price of INR 11/- (Rupees Eleven only) each.
The Special Resolution for the same is put forth in the Postal Ballot Notice dated July 30, 2024. The said
Resolution was duly passed with the requisite majority by the shareholders on August 29, 2024 i.e. on last date for Remote E-Voting for Postal Ballot.
The Company has not moved ahead with the proposed issue of preferential warrants as SEBI, vide its order, has restrained Noticee Nos. 1 to 3 from dealing in securities until further orders. Furthermore, Noticee Nos. 2 and 3 have been restrained from acting as Directors or Key Managerial Personnel of any listed company, its subsidiaries, or SEBI-registered intermediaries. In view of the above restrictions, the Company has decided to defer the preferential warrant issue. This is pursuant to the SEBI order dated October 21, 2024, in the matter of One Life Capital Advisors Limited.
* Again The Board has approved in its Meeting dated May 30, 2025 issuance of upto 18,677,500 (One Crore Eighty Six Lakhs Seventy Seven Thousand Five Hundred) Warrants, each convertible into, or exchangeable for, 1 (one) fully paid-up equity share of the Company of face value of INR 10/- each (Rupees Ten only) ("Warrants") at a price of INR 10/- (Rupees Ten only) each.
The Special Resolution for the same is put one in the Postal Ballot Notice dated June 13, 2025. The said Resolution was duly passed with the requisite majority by the shareholders on July 13, 2025 i.e. on last date for Remote E-Voting for Postal Ballot.
8. DIRECTORS AND KEY MANAGERIAL PERSONNEL:
During the year under review, all the Independent Directors have furnished Declaration of Independence stating that they meet the criteria of independence as provided under Section 149(6) of the Companies Act, 2013 (the Act) and Regulation 16 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) and there has been no change in the circumstances which may affect their status as Independent Directors during the year.
The changes made in the composition of board from the period April 1, 2025 to March 31, 2026:
| Sr. Name of the Director No. | Designation | Date of appointment (Original) | Date of cessation/expiry of term |
| 1. Mr. Rajesh Julal More | Chief Financial Officer | 26/12/2025 | - |
| 2. Mr. Amit Tyagi | Chief Financial Officer | 13/08/2014 | 28/10/2025 |
| 4. Mr. Nitesh Singh | Non- Executive Independent Director | 25 May 2025 |
Note:
Mr Dhananjay Chandrakant Parikh (DIN: 02934120) was re-appointed by the members of the company at the AGM held September 29, 2025 for 2nd term as a Non- Executive Independent Director of the Company, not liable to retire by rotation, for the second consecutive term, i.e., from September 15, 2025 to September 14, 2030 (both days inclusive).
Mr. Amit Tyagi has been appointed as the Chief Financial Officer of the Company w.e.f 13th August, 2014. Mr. Amit Tyagi has over 10 years of experience in the field of Finance, Accounts & Taxation. He had resigned from office with effect from October 28, 2025.
Mr. Rajesh Mores was appointed as CFO of the Company December 12, 2025. He shall hold the office till 5 Years for the post of Chief Financial Officer of the Company. He shall carry on all the duties as that of Chief Financial Officer of the company.
Mrs. Neetu Maurya was appointed as Company Secretary & Compliance Officer of the Company at the board meeting held on January 13, 2025 and he had resigned with effect from May 12, 2026 due to personal reason as specified in his resignation letter received by the Company.
The Board of Directors of Company, on recommendation of Nomination and Remuneration Committee (NRC) has appointed Mr. Ashdullah Khan (A78778) as a Company Secretary & Compliance Office of the Company with effect from July 31, 2026 on the terms and conditions and remuneration as per the draft of the appointment letter placed before the Board.
In accordance with the provision of Section 178 and other applicable provisions of the Act and SEBI Listing Regulations, if any, the Nomination and Remuneration Committee has considered and recommended the above appointments/re-appointments to the Board of Directors and Key Managerial Personnel of the Company. A brief resume and other details of all the Directors seeking appointment/ re-appointment are provided in the Notice of AGM.
Pursuant to the provisions of Section 152(6) of the Act, Mr. Suchit Raghunath Modshing (DIN: 10974977), Executive Non-Independent Director is liable to retires by ration as rational Director at AGM and shall be eligible for re-appointment as Executive Non-Independent Director of the company on approval of shareholders by padding ordinary resolution. He is being eligible, offers herself for re- appointment. The Board recommends his re-appointment.
In accordance with the provisions of Section 2(51) and 203 of the Act read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, following are the Key Managerial Personnel (KMPs) as on 31.03.2026:
| Name | Designation of KMP |
| Mr. Rajesh Julal More | Chief Financial Officer |
| Mrs. Neetu Maurya | Company Secretary & Compliance Officer |
9. COMMITTEES OF THE BOARD:
Audit Committee
M I I
Nomination and Remuneration Committee Stakeholders Relationship Committee Risk Management Committee
Details of terms of reference of the Committees, Committee membership and attendance at meetings of the Committees are provided in the Corporate Governance report.
10. PUBLIC DEPOSITS:
During the financial year 2025-26, your Company has not accepted any deposit within the meaning of Sections 73 and 74 of the Companies Act, 2013 read together with the Companies (Acceptance of Deposits) Rules, 2014.
11. PARTICULARS OF LOANS, INVESTMENTS AND GUARANTEES UNDER SECTION 186 OF THE COMPANIES ACT, 2013:
The particulars of loans given and investments made during the financial year under Section 186 of the Companies Act, 2013 are given at Notes forming part of the Financial Statements. During the financial year, the Company has neither provided any new security nor provided new corporate guarantee for loans availed by the others.
12. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS:
There are no significant and material orders passed by the Regulators/Courts/Tribunal which would impact the going concern status of the Company and its operations in future.
Details of other orders passed by the authorities during the FY 2024-25:
| Authority | Received Date | Particulars | Fine amount | Fines levied for | Comments |
| SEBI | 21st March 2024 | Adjudication Order No. Order/SV/V C/2023 - 24/30164 | 1500000 | The Company has paid the fine. |
Apart from this, The Company has received the Order from Honble High Court of Judicature of Mumbai dated 31st July 2024 uploaded on the Website of the High Court on 2nd August 2024 who has directed the Company under the Writ Petition No. 1114 of 2024 is filed challenging the Order dated 3rd May 2021 passed by the learned Judge, Small Causes Court at Mumbai, inter alia Petitioner is granted liberty to deposit an amount of Rs.3,67,73,382/- before the Small Causes Court on or before 30 September 2024 and also vide order dated 14/10/2024 small causes court had Issue distress warrant under order XXI Rule 43 of Code of Civil Procedure for the amount of Rs.3,67,73,382/-(Rupees Three Crore Sixty Seven Lakh Seventy Three Thousand Three Hundred Eighty Two).The Company is in the process of taking the appropriate actions in the matter.
The Company has also received the Order from Stock Exchange Board of India
| Authority | Received Date | Particulars | Fine amount | Fines for | levied | Comments |
| SEBI | 3rd June 2025 | Adjudication Order No.ORDER/AK/RK/2025 - 26/31449-31460 | 900000 | The Company is under the process of Appeal |
13. CORPORATE SOCIAL RESPONSIBILITY (CSR):
For your Company, Corporate Social Responsibility (CSR) means the integration of social, environmental and economic concerns in its business operations. CSR involves operating Companys business in a manner that meets or exceeds the ethical, legal, commercial and public expectations. In alignment with vision of the Company, through its CSR initiative, your Company will enhance value creation in the society through its services, conduct and initiatives, so as to promote sustained growth for the society. The Board of Directors of your Company has formulated and adopted a policy on CSR which can be accessed at: www.familycarehospitals.com/ and CSR is not applicable for Financial Year 2025-26.
14. EXTRACT OF ANNUAL RETURN:
The draft of Annual Return of the Company in Form MGT-7 in accordance with Section 92(3) of the Companies Act, 2013 is available on the website of the Company at www.scandent.in.
15. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES:
During the period under review, your Company has entered into contract/arrangement with related parties, which were in ordinary course of business and at arms length basis Also, there were related party transactions which could be considered material in accordance with the Policy of the Company on materiality of related party transactions.
All related party transactions are being reviewed and placed before the Audit Committee from time to time for their approval and also been taken on record by the Board.
Your company is the proposed related parties transaction to be enter during FY 2026-27, which has not been approved by the ordinary resolution of shareholders of the company at the meeting held on May 12, 2026 through Postal Ballot. The said resolution was not approved by majority of shareholders who were entity to vote at the meeting.
The information relating to related party transactions is set out in the Form AOC-2 "Annexure 2" to this Report. the disclosure of related party transaction in Form AOC-2 in line with section 134(3) read with Rule 8(2) of the Company(Account)Rule, 2014.
Policy on dealing with related party transactions, is available on the Companys website at www.familycarehospitals.com/
16. CORPORATE GOVERNANCE REPORT AND MANAGEMENT DISCUSSION & ANALYSIS REPORT:
A Report on Corporate Governance along with a Certificate from Practicing Company Secretary confirming the compliance of the conditions of Corporate Governance and Management Discussion and Analysis Report forms part of this Annual Report.
17. MATERIAL CHANGES AND COMMITMENTS AFFECTING FINANCIAL POSITION BETWEEN THE END OF THE FINANCIAL YEAR AND DATE OF REPORT:
a. There was material changes and commitments made by the Company in the financial year 2024-25 which can affect the financial position of the Company.
(i) On September 2024 Company has received notice for termination of Operations and Management Agreement from the landlords for running the hospital at Mira Road, Thane.
The Company has received the Order from Honble High Court of Judicature of Mumbai dated 31st July 2024 uploaded on the Website of the High Court on 2nd August 2024 who has directed the Company under the Writ Petition No. 1114 of 2024 is filed challenging the Order dated 3rd May 2021 passed by the learned Judge, Small Causes Court at Mumbai, inter alia Petitioner is granted liberty to deposit an amount of Rs.3,67,73,382/- before the Small Causes Court on or before 30 September 2024 and also vide order dated 14/10/2024 small causes court had Issue distress warrant under order XXI Rule 43 of Code of Civil Procedure for the amount of Rs.3,67,73,382/-(Rupees Three Crore Sixty Seven Lakh Seventy Three Thousand Three Hundred Eighty Two).The Company is in the process of taking the appropriate actions in the matter.
The above stated developments affected the financial position of the Company.
Your company under review during the FY 2025-26 and as on date of report, no any material change and commitments has been occurred the which can affect the financial position of the Company.
18. NUMBER OF MEETINGS OF THE BOARD:
There were Seven (7) meetings of the Board held during the year. Detailed information is given in the Corporate Governance Report.
19. RETIREMENT BY ROTATION:
Pursuant to the provisions of Section 152(6) of the Act Mr. Suchit Raghunath Modshing (DIN: 10974977) retires by rotation at the ensuing Annual General Meeting, and being eligible offers himself for reappointment. Appropriate resolution for his reappointment is being placed for the approval by the Members of the Company at the ensuing Annual General Meeting (AGM).
A brief profile of Mr. Suchit Raghunath Modshing and other related information is detailed in the Notice convening the 32nd AGM of your Company.
The Board considered the said re-appointment in the interest of the Company and hence recommends the same to the Members for approval.
20. DISCLOSURE RELATING TO REMUNERATION OF DIRECTORS, KEY MANAGERIAL PERSONNEL AND PARTICULARS OF EMPLOYEES:
Your Company has been following well laid down policy on appointment and remuneration of Directors, KMP and Senior Management Personnel.
The appointment of Directors is made pursuant to the recommendation of Nomination and Remuneration Committee (NRC). Approval of shareholders for payment of remuneration to Whole Time Directors is sought, from time to time.
The remuneration of Non-Executive Directors comprises of sitting fees in accordance with the provisions of Companies Act, 2013 incurred in connection with attending the Board meetings, Committee meetings, General meetings and in relation to the business of the Company. During the year under review, the Company has not paid any commission to the Non-Executive Directors.
A brief of the Remuneration Policy on appointment and remuneration of Directors, KMP and Senior Management is provided in the Report on Corporate Governance forming part of this Annual Report. Further, the Policy is available on the website of the Company and the web link thereto is www.familycarehospitals.com/
NRC have also formulated criteria for determining qualifications, positive attributes and independence of a director and the same have been provided in the Report on Corporate Governance forming part of this Annual Report.
The information required under Section 197 of the Companies Act, 2013 read with Companies Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect of Directors/ employees of your Company is set out in "Annexure 3" to this Report.
21. DECLARATION OF INDEPENDENCE:
The Company has received necessary declaration from each Independent Director under section 149 (7) of the Act that he / she meets the criteria of independence laid down in Section 149(6) of the Act and Regulation 16 of SEBI Listing Regulations.
22. BOARD EVALUATION:
One of the key functions of the Board is to monitor and review the Board evaluation framework. The Board of Directors has carried out an annual evaluation of its own performance, Committees and Individual Directors pursuant to provision of the Act and the Corporate Governance requirement as prescribed by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulation, 2015").
The performance of the Board was evaluated by the board after seeking inputs from all the directors on the basis of the criteria such as the Board composition, structure of the board process, information and functioning, etc.
The Board also carried annual performance evaluation of the working of its Audit, Nomination and Remuneration Committee, Risk Management Committee as well as Stakeholder Relationship Committee. The Board and the Nomination and Remuneration Committee reviewed the performance of the individual Directors.
In a separate meeting of the Independent Director, performance of non -independent Director, performance of Board and performance of the chairman was evaluated, taking in to account the view of Executive Director and Non Executive Director. Performance evaluation of Independent Director was done by the entire Board, excluding the Independent Director being evaluated.
Separate Meeting of the Independent Directors
The Independent Directors held a Meeting on March 25, 2026, without the attendance of Non-Independent Directors and Members of Management. All the Independent Directors were present at such meeting and at the Meeting they have:
i. Reviewed the performance of non-independent directors and the Board as a whole;
ii. Assessed the quality, quantity and timelines of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties.
The Present Independent Directors holds a unanimous opinion that the Non-Independent Directors bring to the Board constructive knowledge in their respective field. All the Directors effectively participate and interact in the Meeting. The information flow between the Companys Management and the Board is satisfactory.
Training of Independent Directors
The Company shall provide regular training to independent directors to update them with the regulatory changes and their roles and responsibility in view thereof.
23. STATUTORY AUDITORS AND AUDITOR REPORT:
In accordance with the provisions of Section 139(8) of the Companies Act, 2013, M/s. Rafik & Associates, Chartered Accountants (FRN 146573W) was appointed as statutory auditor of the company for a term of 5 consecutive 5year commencement form conclusion of from the conclusion of this 31st Annual General Meeting held on September 29, 2025 till the conclusion of the 36th Annual General Meeting to be held in the year 2030. to examine and audit the accounts of the Company at such remuneration as may be decided by the Board of Directors in consultation with the Statutory Auditors of the Company."
The Audit Committee reviews the independence of the Auditors and the effectiveness of the Audit process. The report issued by M/s. Parekh Sharma and M/s. Rafik & Associates on the financial statements of the Company for the financial year ended March 31, 2026 forms part of the Annual Report. The Notes on financial statement referred to in the Auditors Report are self-explanatory and do contain any qualification(s), reservation(s) or adverse remark and forms as integral part of financial statements of the Company.
24. SECRETARIAL AUDITOR:
Since your Company meet the criteria as per provisions of Section 204 of the Act, read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 24A of the Listing Regulations, 2015 the secretarial audit Report is applicable.
Your Company was appointed Mr. Ajay Kumar of M/s. Ajay Kumar & Co., Company Secretaries in Practices as the Secretarial Auditor of the Company for a term of five years, commencing from FY 2025 -26 to FY 2029-30 by the members of the Company at the Annual General Meeting held on September 29, 2025.
The Secretarial Audit Report for FY 2025-26, as required under the aforesaid provisions, is appended herewith as Annexure 4 and form parts of this report.
The said report does not contain any qualification, reservation, or adverse remark. The Secretarial Auditors of the Company have not reported any fraud as specified under the second proviso of Section 143(12) of the Companies Act, 2013 (including any statutory modification(s) or reenactment(s) for the time being in force).
25. COST AUDITORS:
Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section 148 (1) of the Companies Act, 2013 are not applicable to the Company for the FY 2025-26.
26. INTERNAL CONTROL:
Pursuant to the provisions of Section 138 of the Act read with the Companies (Accounts) Rules, 2014 M/s. V H U D & Associates, Chartered accountants., were appointed as Internal Auditors to undertake internal audit of the Company for FY 2025-26.
The Internal Audit Report does not contain any qualification, reservation, or adverse remark.
The Internal Auditors of the Company have not reported any fraud as specified under the second proviso of Section 143(12) of the Companies Act, 2013 (including any statutory modification(s) or re-enactment(s) for the time being in force).
27. HUMAN RESOURCE
a. Disclosure with regard to Prevention of Sexual Harassment at Workplace:
In line with the requirements of the Sexual Harassment of Workman at Workplace (Prevention, Prohibition and Redressed) Act. 2013 (POSH Act"), your Company has developed and implemented a Prevention of Sexual Harassment of Woman at Workplace Policy (POSH Policy"), as a part of Overall ethics framework adopted by the Company.
During the year under review, no compliant was receive and were no compliant pending from the previous of the POSH Act. The Company has zero tolerance for sexual harassment at the work place.
Summary of sexual harassment issues raised attended and dispensed during financial year 2025-26:
No. of complaints received: Nil
No. of complaints disposed off: Nil
No. of cases pending for more than 90 days: Nil
b. Maternity Benefit:
In line with the provision of Rule 8(5)(XIII) of the Companies (Accounts) Rule 2014, your Company hereby confirms that Company has duly complied with all the applicable provisions relating to the Maternity Benefit Act, 1961.
c. Employee Strength:
AT the end of Closure of period under review, Company has Seven (7) male employee.
28. LISTING OF EQUITY SHARES:
Pursuant to the provisions of Listing Agreement with the Stock Exchanges, the Company declares that the Equity Shares of the Company are listed at the BSE Limited.
The Company confirms that it has paid Annual Listing Fees due to BSE Limited up to the Financial Year - 2025-26.
29. DIRECTORS RESPONSIBILITY STATEMENT:
Pursuant to the requirement under section 134(3) (c) of the Companies Act, 2013, the board of Director, to the best of their knowledge and ability, confirm that:
i. In the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures;
ii. They have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the Profit of the Company for year under review;
iii. They have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
iv. They have prepared the annual accounts on a going concern basis.
v. They have laid down internal financial controls, which are adequate and are operating efficiently.
vi. They have devised proper systems to ensure compliance with the provisions of all applicable laws and such systems are adequate and operating effectively.
30. RISK MANAGEMENT:
Your Company recognizes that risk is an integral part of business and is committed to managing the risks in a proactive and efficient manner. Your Company periodically assesses risks in the internal and external environment, along with the cost of treating risks and incorporates risk treatment plans in its strategy, business and operational plans.
Your Company, through its risk management process, strives to contain impact and likelihood of the risks within the risk appetite as agreed from time to time with the Board of Directors.
In Line with the regulatory requirement, the Company has constituted a Risk Management Committee to oversee the risk management. The details of the Committee along with its charter are set out in the Corporate Governance Report forming part of this Report. The Risk Management Policy is also posted on the website of the Company at www.familycarehospitals.com/
31. VIGIL MECHANISM/WHISTLE BLOWER:
Your Company is committed to highest standards of ethical, moral and legal business conduct. The Company has adopted a Whistle Blower Policy and has established the necessary vigil mechanism which is in compliance with the provisions of Section 177 (10) of the Companies Act, 2013 and under Regulation 22 of SEBI Listing Regulations 2015, for directors and employees to report concerns about unethical behavior. No person has been denied access to the Chairman of the audit committee. The said policy has been also put up on the website of the Company at the following link: www.familycarehospitals.com/
The policy provides for a framework and process whereby concerns can be raised by its employees against any kind of discrimination, harassment, victimization or any other unfair practice being adopted against them.
32. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION & FOREIGN EXCHANGE EARNING & OUTGOINGS:
The particulars as prescribed under sub- section (3) (m) of Section 134 of the Companies Act, 2013, read with Companies (Accounts) Rules, 2014 are hereunder:
a) Conservation of energy
The operations of the Company are not energy-intensive. However, significant measures are being taken to reduce the energy consumption by using energy-efficient equipment. Your Company constantly evaluates and invests in new technology to make its infrastructure more energy efficient.
(b) Technology absorption
Over the years, your Company has partnered with technology personnel, companies and initiatives including majorly with Ready Technologies, a unit of Onelife Capital Advisors Ltd, (a promoter group entity) to build and get access to the latest and customized software that can enhance user experience and ERPs to gain efficiencies in the internal functioning of the company. We are happy to have develop and integrate open AI platforms with our 911 product with new features and a completely new application with this association. In its continuous endeavor to serve the patients better and to bring healthcare of international standards.
(c) Foreign Exchange earning & outgoings
| For Year Ended 31st March 2025 | For Year Ended 31st March 2026 | |
| Expenditure- | ||
| Foreign Travel | NIL | NIL |
| Freight Forwarding Expenses | NIL | NIL |
| Income- | ||
| Commission and other income | NIL | NIL |
33. DISCLOSURE IN RELATION TO THE UTILIZATION OF THE FUNDS RAISED
The Company has not raised the fund by way of right issue during in financial year 2025-26.
34. CHANGE IN NATURE OF BUSINESS
There was no change in the nature of business of the Company during the Financial Year 2025-26.
35. COMPLIANCE OF SECRETARIAL STANDARDS
Your Company have devised proper system and processes to ensure requisite compliance of applicable Secretarial Standard issued by the Institute of Company Secretaries of India and that such system is adhere to. The Company has duly complied with Secretarial Standards issued by the Institute of Company Secretaries of India on Meetings of the Board of Directors (SS-1) and Members (SS-2).
36. FRAUDS:
During the year under review, neither the statutory auditors nor the secretarial auditor has reported to the audit committee, under section 143(12) of the Act, any instances of fraud committed against the Company by its officers or employees, the details of which would need to be mentioned in the Directors Report.
37. GENERAL DISCLOSURE
During the year under review, there is no application made and/ or no proceeding pending under the Insolvency and Bankruptcy Code, 2016.
During the year under review, requirement of disclosing details of difference between amount of the valuation done at the time of onetime settlement and the valuation done while taking loan from the Banks or Financial Institutions along with the reasons thereof is not applicable on the Company.
38. CAUTIONARY STATEMENT:
Certain statements in the Directors Report describing the Companys objectives, projections, estimates, expectations or predictions may be forward-looking statements within the meaning of applicable securities laws and regulations. Actual results could differ from those expressed or implied. Important factors that could make a difference to the Companys operations include labour and material availability, and prices, cyclical demand and pricing in the Companys principal markets, changes in government regulations, tax regimes, economic.
39. MALWARE / CYBER SECURITY INCIDENT AFFECTING THE INFORMATION TECHNOLOGY SYSTEMS
Since your Company was suffered an malware / cyber security incident affecting the information technology systems on January 30, 2026. your company was intimated to stock exchange under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereof, on January 31, 2026.
Your Company has strong date security plan and strategy to protect the date and ensure form such malware/ cyber security incident in future.
40. ACKNOWLEDGEMENTS:
The Board of Directors wish to place on record its deep sense of appreciation for the committed services by all the employees of the Company. The Board also expresses its gratitude and appreciates the assistance and co-operation received from the Banks, Government Authorities, Customers, Shareholders and other Stakeholders during the year under review.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.